

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.39324602 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.39324602 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.81674398 |
| 4 | natural killer cell mediated immunity (GO:0002228) | 4.79834963 |
| 5 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.79834963 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 4.72499680 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.44268032 |
| 8 | histone H3-K4 trimethylation (GO:0080182) | 4.22345648 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.19632018 |
| 10 | B cell homeostasis (GO:0001782) | 4.18131834 |
| 11 | neutrophil mediated immunity (GO:0002446) | 4.12209281 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07069587 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07069587 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07069587 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.07069587 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07069587 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.07069587 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98997636 |
| 19 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.96374663 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 3.82153626 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.81441461 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.80967229 |
| 23 | positive regulation of receptor recycling (GO:0001921) | 3.79981826 |
| 24 | hepatocyte apoptotic process (GO:0097284) | 3.79033682 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.78668724 |
| 26 | hypotonic response (GO:0006971) | 3.74237390 |
| 27 | microglial cell activation (GO:0001774) | 3.73971436 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.72436682 |
| 29 | modulation by symbiont of host cellular process (GO:0044068) | 3.68924410 |
| 30 | germinal center formation (GO:0002467) | 3.65332732 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.61238283 |
| 32 | protein localization to endosome (GO:0036010) | 3.57335753 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56872263 |
| 34 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.55159657 |
| 35 | positive T cell selection (GO:0043368) | 3.53768322 |
| 36 | cortical actin cytoskeleton organization (GO:0030866) | 3.42238605 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.36912639 |
| 38 | negative T cell selection (GO:0043383) | 3.34284171 |
| 39 | I-kappaB phosphorylation (GO:0007252) | 3.33896213 |
| 40 | macroautophagy (GO:0016236) | 3.33161881 |
| 41 | cell adhesion mediated by integrin (GO:0033627) | 3.32496648 |
| 42 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.32363407 |
| 43 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.32363407 |
| 44 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.32363407 |
| 45 | negative regulation of anoikis (GO:2000811) | 3.31347649 |
| 46 | G-protein coupled receptor internalization (GO:0002031) | 3.24898191 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.24505681 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.22586421 |
| 49 | regulation of germinal center formation (GO:0002634) | 3.20226264 |
| 50 | modulation by virus of host process (GO:0019054) | 3.18162124 |
| 51 | myeloid leukocyte mediated immunity (GO:0002444) | 3.16326952 |
| 52 | regulation of integrin activation (GO:0033623) | 3.13482589 |
| 53 | membrane raft organization (GO:0031579) | 3.13255063 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 3.11240114 |
| 55 | macrophage activation (GO:0042116) | 3.07956305 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.06014518 |
| 57 | cortical cytoskeleton organization (GO:0030865) | 3.05656251 |
| 58 | negative regulation of DNA repair (GO:0045738) | 3.05469795 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.04872140 |
| 60 | cellular response to ethanol (GO:0071361) | 3.03109489 |
| 61 | blood vessel maturation (GO:0001955) | 3.02730437 |
| 62 | substrate-dependent cell migration (GO:0006929) | 3.02565519 |
| 63 | positive regulation of fibroblast migration (GO:0010763) | 3.00155086 |
| 64 | B cell proliferation (GO:0042100) | 3.00124092 |
| 65 | regulation of necroptotic process (GO:0060544) | 2.99222042 |
| 66 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98966467 |
| 67 | cellular extravasation (GO:0045123) | 2.98496364 |
| 68 | tolerance induction (GO:0002507) | 2.98036363 |
| 69 | negative regulation of granulocyte differentiation (GO:0030853) | 2.96183005 |
| 70 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.92761468 |
| 71 | sprouting angiogenesis (GO:0002040) | 2.91922231 |
| 72 | peptidyl-lysine trimethylation (GO:0018023) | 2.89498204 |
| 73 | dosage compensation (GO:0007549) | 2.87467462 |
| 74 | negative regulation of osteoblast proliferation (GO:0033689) | 2.86858706 |
| 75 | endodermal cell differentiation (GO:0035987) | 2.85052596 |
| 76 | developmental pigmentation (GO:0048066) | 2.85029802 |
| 77 | T cell mediated immunity (GO:0002456) | 2.84393430 |
| 78 | mature B cell differentiation (GO:0002335) | 2.84186892 |
| 79 | thymic T cell selection (GO:0045061) | 2.84052002 |
| 80 | T cell selection (GO:0045058) | 2.83888337 |
| 81 | leukocyte mediated cytotoxicity (GO:0001909) | 2.83574194 |
| 82 | mitotic sister chromatid cohesion (GO:0007064) | 2.83033301 |
| 83 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.82772365 |
| 84 | negative regulation of interleukin-1 production (GO:0032692) | 2.82647743 |
| 85 | early endosome to late endosome transport (GO:0045022) | 2.82052914 |
| 86 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.81369507 |
| 87 | pericardium development (GO:0060039) | 2.80587915 |
| 88 | regulation of macrophage cytokine production (GO:0010935) | 2.80327679 |
| 89 | response to host immune response (GO:0052572) | 2.80207473 |
| 90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80207473 |
| 91 | negative regulation of B cell proliferation (GO:0030889) | 2.78556044 |
| 92 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78282851 |
| 93 | wound healing, spreading of epidermal cells (GO:0035313) | 2.77896828 |
| 94 | defense response to protozoan (GO:0042832) | 2.77709237 |
| 95 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.77604812 |
| 96 | nuclear pore complex assembly (GO:0051292) | 2.77026238 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.75085916 |
| 98 | histone H3-K36 demethylation (GO:0070544) | 2.75005480 |
| 99 | lymphocyte homeostasis (GO:0002260) | 2.73498083 |
| 100 | histone H3-K4 methylation (GO:0051568) | 2.73448128 |
| 101 | histone-serine phosphorylation (GO:0035404) | 2.73302890 |
| 102 | positive regulation of macrophage cytokine production (GO:0060907) | 2.73037212 |
| 103 | neutrophil activation (GO:0042119) | 2.72285236 |
| 104 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.69032126 |
| 105 | detection of external biotic stimulus (GO:0098581) | 2.68686354 |
| 106 | synaptic vesicle endocytosis (GO:0048488) | 2.66441064 |
| 107 | heterotypic cell-cell adhesion (GO:0034113) | 2.65792783 |
| 108 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.65444873 |
| 109 | response to host (GO:0075136) | 2.64869082 |
| 110 | response to host defenses (GO:0052200) | 2.64869082 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64869082 |
| 112 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.63314100 |
| 113 | regulation of DNA endoreduplication (GO:0032875) | 2.63093458 |
| 114 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.59954961 |
| 115 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.58711428 |
| 116 | regulation of anoikis (GO:2000209) | 2.57722677 |
| 117 | vesicle transport along microtubule (GO:0047496) | 2.57249216 |
| 118 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55586232 |
| 119 | skin morphogenesis (GO:0043589) | 2.55558131 |
| 120 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.55182296 |
| 121 | granulocyte activation (GO:0036230) | 2.54443439 |
| 122 | phospholipid translocation (GO:0045332) | 2.54023167 |
| 123 | lipid translocation (GO:0034204) | 2.54023167 |
| 124 | cell-substrate junction assembly (GO:0007044) | 2.52666234 |
| 125 | mesodermal cell differentiation (GO:0048333) | 2.52274867 |
| 126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.50992510 |
| 127 | protein targeting to vacuole (GO:0006623) | 2.50287486 |
| 128 | protein targeting to lysosome (GO:0006622) | 2.50287486 |
| 129 | establishment of protein localization to vacuole (GO:0072666) | 2.50287486 |
| 130 | response to magnesium ion (GO:0032026) | 2.48738689 |
| 131 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.48531138 |
| 132 | histone mRNA catabolic process (GO:0071044) | 2.47261651 |
| 133 | phospholipid homeostasis (GO:0055091) | 2.46993067 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.46892959 |
| 135 | regulation of B cell proliferation (GO:0030888) | 2.46280539 |
| 136 | negative regulation of interleukin-17 production (GO:0032700) | 2.45743610 |
| 137 | import into cell (GO:0098657) | 2.44915791 |
| 138 | positive regulation of interferon-alpha production (GO:0032727) | 2.44344236 |
| 139 | negative regulation of monooxygenase activity (GO:0032769) | 2.44298985 |
| 140 | cytokine secretion (GO:0050663) | 2.43146159 |
| 141 | regulation of platelet aggregation (GO:0090330) | 2.42862045 |
| 142 | clathrin coat assembly (GO:0048268) | 2.42787591 |
| 143 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.41974111 |
| 144 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.41384687 |
| 145 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.41350958 |
| 146 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.41335155 |
| 147 | wound healing, spreading of cells (GO:0044319) | 2.41045637 |
| 148 | regulation of ARF GTPase activity (GO:0032312) | 2.40564515 |
| 149 | stress fiber assembly (GO:0043149) | 2.40431277 |
| 150 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.38935551 |
| 151 | regulation of protein polyubiquitination (GO:1902914) | 2.38766150 |
| 152 | regulation of interferon-alpha production (GO:0032647) | 2.38244671 |
| 153 | positive regulation of granulocyte differentiation (GO:0030854) | 2.36613258 |
| 154 | positive regulation of Rac GTPase activity (GO:0032855) | 2.35861046 |
| 155 | NLS-bearing protein import into nucleus (GO:0006607) | 2.35213969 |
| 156 | peptidyl-serine phosphorylation (GO:0018105) | 2.34353120 |
| 157 | positive regulation of B cell proliferation (GO:0030890) | 2.34232853 |
| 158 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.34178056 |
| 159 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.33745514 |
| 160 | lymphocyte proliferation (GO:0046651) | 2.33084263 |
| 161 | protein K48-linked deubiquitination (GO:0071108) | 2.32953892 |
| 162 | histone lysine methylation (GO:0034968) | 2.32936147 |
| 163 | T cell homeostasis (GO:0043029) | 2.32843823 |
| 164 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.32596611 |
| 165 | regulation of beta-amyloid formation (GO:1902003) | 2.32339234 |
| 166 | activated T cell proliferation (GO:0050798) | 2.32269270 |
| 167 | embryonic process involved in female pregnancy (GO:0060136) | 2.31908981 |
| 168 | peptidyl-threonine phosphorylation (GO:0018107) | 2.28887683 |
| 169 | extracellular fibril organization (GO:0043206) | 2.28810656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.45387753 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.28693256 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.79595379 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.35311799 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34607580 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.15742746 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09475322 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92616566 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.86848201 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.85460736 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.84046099 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76502695 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.53289318 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.49350166 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47269295 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.44087456 |
| 17 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.38163677 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31873857 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.30282218 |
| 20 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.29022791 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28368985 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25577717 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.24821163 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12627278 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.11860745 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04690240 |
| 27 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.91354538 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82621998 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.81914803 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77066375 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.75628590 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.72458302 |
| 33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.67250659 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.66863627 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63858848 |
| 36 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.61892613 |
| 37 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.61892613 |
| 38 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.61518203 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56498854 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56127258 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.55858705 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.54237950 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52912399 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51997533 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51124052 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48094882 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45655018 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44311310 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44115893 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.43345536 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42733850 |
| 52 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41595672 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41460426 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39649756 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39437549 |
| 56 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38772365 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35451136 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35449571 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34008579 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34008579 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30892321 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28755565 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27300307 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26962089 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.25001550 |
| 66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24160658 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23972443 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22632685 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20667375 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20291982 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19546928 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19081439 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17398902 |
| 74 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.17253398 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17056641 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16266882 |
| 77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14136085 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13733286 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12796596 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12796596 |
| 81 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12713307 |
| 82 | MYC_22102868_ChIP-Seq_BL_Human | 1.12308803 |
| 83 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.12122561 |
| 84 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11585427 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11049439 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10778653 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09921109 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09284664 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07900092 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07512217 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05049265 |
| 92 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03542497 |
| 93 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.03522669 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02347472 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01796179 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01485837 |
| 97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00982760 |
| 98 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00964121 |
| 99 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.00004393 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99948873 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98108634 |
| 102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97233690 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96082928 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96073374 |
| 105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96037788 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94847033 |
| 107 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93769862 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92303578 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91800690 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91436004 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91364599 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90916699 |
| 113 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90862220 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90719135 |
| 115 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.87750659 |
| 116 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86438527 |
| 117 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86424727 |
| 118 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85684871 |
| 119 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85610888 |
| 120 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84652232 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84512909 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84481173 |
| 123 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84360767 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84230522 |
| 125 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83816966 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83764992 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83762391 |
| 128 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83503107 |
| 129 | EWS_26573619_Chip-Seq_HEK293_Human | 0.82889953 |
| 130 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82279070 |
| 131 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.82226965 |
| 132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82081758 |
| 133 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81614904 |
| 134 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.81282944 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.81116469 |
| 136 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79681426 |
| 137 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.76757371 |
| 138 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.76485590 |
| 139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75691616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.99567933 |
| 2 | MP0005174_abnormal_tail_pigmentation | 3.85293568 |
| 3 | MP0000015_abnormal_ear_pigmentation | 3.42974264 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.20725658 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.15834914 |
| 6 | MP0009278_abnormal_bone_marrow | 2.89539030 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.70192510 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.60248552 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.46830277 |
| 10 | MP0003279_aneurysm | 2.45516727 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.41203228 |
| 12 | MP0003828_pulmonary_edema | 2.30839303 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.29867581 |
| 14 | MP0010368_abnormal_lymphatic_system | 2.28829040 |
| 15 | MP0001800_abnormal_humoral_immune | 2.27895609 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.22850400 |
| 17 | MP0004510_myositis | 2.21779535 |
| 18 | MP0006054_spinal_hemorrhage | 2.14541235 |
| 19 | MP0002006_tumorigenesis | 2.11501141 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.07302018 |
| 21 | MP0000569_abnormal_digit_pigmentation | 10.0962815 |
| 22 | MP0005623_abnormal_meninges_morphology | 1.97233467 |
| 23 | MP0004883_abnormal_blood_vessel | 1.96962093 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.92942062 |
| 25 | MP0003787_abnormal_imprinting | 1.88189645 |
| 26 | MP0004272_abnormal_basement_membrane | 1.88008013 |
| 27 | MP0003724_increased_susceptibility_to | 1.87908558 |
| 28 | MP0000371_diluted_coat_color | 1.87377181 |
| 29 | MP0000685_abnormal_immune_system | 1.86575431 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.86409550 |
| 31 | MP0005451_abnormal_body_composition | 1.84178975 |
| 32 | MP0001790_abnormal_immune_system | 1.83222747 |
| 33 | MP0005387_immune_system_phenotype | 1.83222747 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.83021644 |
| 35 | MP0002723_abnormal_immune_serum | 1.79856004 |
| 36 | MP0002419_abnormal_innate_immunity | 1.78860606 |
| 37 | MP0005671_abnormal_response_to | 1.77798565 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.76892134 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.74793522 |
| 40 | MP0000767_abnormal_smooth_muscle | 1.69092714 |
| 41 | MP0001819_abnormal_immune_cell | 1.67537685 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.67494436 |
| 43 | MP0005164_abnormal_response_to | 1.66633793 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.62757839 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.62757839 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.62411959 |
| 47 | MP0003303_peritoneal_inflammation | 1.60838915 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.60479404 |
| 49 | MP0005275_abnormal_skin_tensile | 1.60187879 |
| 50 | MP0002398_abnormal_bone_marrow | 1.57263535 |
| 51 | MP0005023_abnormal_wound_healing | 1.54330930 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.49687919 |
| 53 | MP0001873_stomach_inflammation | 1.48953053 |
| 54 | MP0004947_skin_inflammation | 1.44899422 |
| 55 | MP0002009_preneoplasia | 1.44328139 |
| 56 | MP0008057_abnormal_DNA_replication | 1.41339711 |
| 57 | MP0003221_abnormal_cardiomyocyte_apopto | 1.39786667 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.38839875 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.38689496 |
| 60 | MP0005025_abnormal_response_to | 1.37568817 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.37283446 |
| 62 | MP0003436_decreased_susceptibility_to | 1.36366962 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.34441403 |
| 64 | MP0000716_abnormal_immune_system | 1.34210638 |
| 65 | MP0005257_abnormal_intraocular_pressure | 1.33666479 |
| 66 | MP0009046_muscle_twitch | 1.28466023 |
| 67 | MP0001915_intracranial_hemorrhage | 1.27567371 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.27167669 |
| 69 | MP0005503_abnormal_tendon_morphology | 1.24596354 |
| 70 | MP0002405_respiratory_system_inflammati | 1.23826904 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.20845832 |
| 72 | MP0002722_abnormal_immune_system | 1.20353394 |
| 73 | MP0005595_abnormal_vascular_smooth | 1.20240360 |
| 74 | MP0010307_abnormal_tumor_latency | 1.19221651 |
| 75 | MP0001958_emphysema | 1.15291346 |
| 76 | MP0004859_abnormal_synaptic_plasticity | 1.12262433 |
| 77 | MP0003329_amyloid_beta_deposits | 1.05247707 |
| 78 | MP0002060_abnormal_skin_morphology | 1.05220929 |
| 79 | MP0004484_altered_response_of | 1.04640159 |
| 80 | MP0001853_heart_inflammation | 1.03137524 |
| 81 | MP0002429_abnormal_blood_cell | 1.02334477 |
| 82 | MP0000249_abnormal_blood_vessel | 1.00796617 |
| 83 | MP0003448_altered_tumor_morphology | 1.00662969 |
| 84 | MP0004381_abnormal_hair_follicle | 0.99851972 |
| 85 | MP0003091_abnormal_cell_migration | 0.97993359 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.97901154 |
| 87 | MP0002075_abnormal_coat/hair_pigmentati | 0.97230249 |
| 88 | MP0005409_darkened_coat_color | 0.94176715 |
| 89 | MP0000733_abnormal_muscle_development | 0.91814091 |
| 90 | MP0006082_CNS_inflammation | 0.91641664 |
| 91 | MP0002133_abnormal_respiratory_system | 0.91167035 |
| 92 | MP0005388_respiratory_system_phenotype | 0.91167035 |
| 93 | MP0002928_abnormal_bile_duct | 0.89834564 |
| 94 | MP0000604_amyloidosis | 0.88927566 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.86088062 |
| 96 | MP0000428_abnormal_craniofacial_morphol | 0.85112184 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.83909696 |
| 98 | MP0003690_abnormal_glial_cell | 0.83796391 |
| 99 | MP0001851_eye_inflammation | 0.83302263 |
| 100 | MP0010094_abnormal_chromosome_stability | 0.83213740 |
| 101 | MP0004084_abnormal_cardiac_muscle | 0.82017503 |
| 102 | MP0008961_abnormal_basal_metabolism | 0.81505556 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.81415717 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.81012130 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 0.80706968 |
| 106 | MP0003045_fibrosis | 0.80116556 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.80013333 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.79976556 |
| 109 | MP0002168_other_aberrant_phenotype | 0.78332388 |
| 110 | MP0004233_abnormal_muscle_weight | 0.76948016 |
| 111 | MP0003866_abnormal_defecation | 0.73304956 |
| 112 | MP0005621_abnormal_cell_physiology | 0.72399936 |
| 113 | MP0002128_abnormal_blood_circulation | 0.71596248 |
| 114 | MP0009785_altered_susceptibility_to | 0.70584312 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.69843515 |
| 116 | MP0001243_abnormal_dermal_layer | 0.68870063 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.68753500 |
| 118 | MP0008260_abnormal_autophagy | 0.68256020 |
| 119 | MP0008569_lethality_at_weaning | 0.68068792 |
| 120 | MP0002925_abnormal_cardiovascular_devel | 0.67301285 |
| 121 | MP0005165_increased_susceptibility_to | 0.67252581 |
| 122 | MP0001542_abnormal_bone_strength | 0.67123581 |
| 123 | MP0001186_pigmentation_phenotype | 0.66953049 |
| 124 | MP0005423_abnormal_somatic_nervous | 0.66544653 |
| 125 | MP0004811_abnormal_neuron_physiology | 0.65775379 |
| 126 | MP0009745_abnormal_behavioral_response | 0.61723231 |
| 127 | MP0002067_abnormal_sensory_capabilities | 0.61704489 |
| 128 | MP0003635_abnormal_synaptic_transmissio | 0.61124151 |
| 129 | MP0002064_seizures | 0.59097172 |
| 130 | MP0000858_altered_metastatic_potential | 0.56984806 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.56613406 |
| 132 | MP0005310_abnormal_salivary_gland | 0.56552273 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.54107707 |
| 134 | MP0002933_joint_inflammation | 0.53176513 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.53076423 |
| 136 | MP0008058_abnormal_DNA_repair | 0.52941041 |
| 137 | MP0004742_abnormal_vestibular_system | 0.52745509 |
| 138 | MP0005384_cellular_phenotype | 0.52708547 |
| 139 | MP0003634_abnormal_glial_cell | 0.51819734 |
| 140 | MP0002063_abnormal_learning/memory/cond | 0.50662665 |
| 141 | MP0005386_behavior/neurological_phenoty | 0.50278404 |
| 142 | MP0004924_abnormal_behavior | 0.50278404 |
| 143 | MP0002572_abnormal_emotion/affect_behav | 0.49515089 |
| 144 | MP0002254_reproductive_system_inflammat | 0.47117939 |
| 145 | MP0000465_gastrointestinal_hemorrhage | 0.46427995 |
| 146 | MP0000778_abnormal_nervous_system | 0.45530842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.06790073 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.89844594 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.52011014 |
| 4 | Premature rupture of membranes (HP:0001788) | 4.01988161 |
| 5 | Arterial tortuosity (HP:0005116) | 3.95755820 |
| 6 | Vascular tortuosity (HP:0004948) | 3.91130236 |
| 7 | Abnormality of the fingertips (HP:0001211) | 3.79607899 |
| 8 | Peritonitis (HP:0002586) | 3.77830754 |
| 9 | Aortic aneurysm (HP:0004942) | 3.75183350 |
| 10 | Aortic dissection (HP:0002647) | 3.62083922 |
| 11 | Stomatitis (HP:0010280) | 3.54156558 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.49984434 |
| 13 | Absent frontal sinuses (HP:0002688) | 3.46680511 |
| 14 | Periodontitis (HP:0000704) | 3.42386126 |
| 15 | Osteolytic defects of the hand bones (HP:0009699) | 3.22590690 |
| 16 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.22590690 |
| 17 | Spondylolisthesis (HP:0003302) | 3.20767981 |
| 18 | Recurrent skin infections (HP:0001581) | 3.18429284 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.18355106 |
| 20 | Gingivitis (HP:0000230) | 3.09962564 |
| 21 | Prostate neoplasm (HP:0100787) | 3.09347075 |
| 22 | Recurrent viral infections (HP:0004429) | 3.08539115 |
| 23 | Conjunctival telangiectasia (HP:0000524) | 3.06948598 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.06329105 |
| 25 | Large earlobe (HP:0009748) | 2.98557140 |
| 26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.96284428 |
| 27 | Thyroiditis (HP:0100646) | 2.92105036 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.91720970 |
| 29 | Thoracolumbar scoliosis (HP:0002944) | 2.87705909 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86491345 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86491345 |
| 32 | Volvulus (HP:0002580) | 2.84965152 |
| 33 | Spontaneous hematomas (HP:0007420) | 2.77920608 |
| 34 | Subacute progressive viral hepatitis (HP:0006572) | 2.77394834 |
| 35 | Macroorchidism (HP:0000053) | 2.74452242 |
| 36 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.73848373 |
| 37 | Ankle contracture (HP:0006466) | 2.73843784 |
| 38 | Optic neuritis (HP:0100653) | 2.72195171 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.72195171 |
| 40 | Wormian bones (HP:0002645) | 2.70802041 |
| 41 | Overgrowth (HP:0001548) | 2.70666514 |
| 42 | Generalized hypopigmentation (HP:0007513) | 2.64107986 |
| 43 | Colitis (HP:0002583) | 2.62346887 |
| 44 | Glucose intolerance (HP:0000833) | 2.62256332 |
| 45 | Febrile seizures (HP:0002373) | 2.61940657 |
| 46 | Mitral valve prolapse (HP:0001634) | 2.61804077 |
| 47 | Dilatation of the ascending aorta (HP:0005111) | 2.61723593 |
| 48 | Frequent falls (HP:0002359) | 2.60039296 |
| 49 | Heterotopia (HP:0002282) | 2.54809357 |
| 50 | Submucous cleft hard palate (HP:0000176) | 2.49885717 |
| 51 | T lymphocytopenia (HP:0005403) | 2.42777480 |
| 52 | Atrophic scars (HP:0001075) | 2.41700587 |
| 53 | Leukocytosis (HP:0001974) | 2.40331766 |
| 54 | Genu recurvatum (HP:0002816) | 2.40025731 |
| 55 | Narrow palate (HP:0000189) | 2.38415362 |
| 56 | Premature loss of primary teeth (HP:0006323) | 2.36124539 |
| 57 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.35458246 |
| 58 | Vasculitis (HP:0002633) | 2.34234476 |
| 59 | Myositis (HP:0100614) | 2.33969531 |
| 60 | Abnormality of the frontal sinuses (HP:0002687) | 2.33905691 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.30846260 |
| 62 | Hematochezia (HP:0002573) | 2.30260545 |
| 63 | Cervical subluxation (HP:0003308) | 2.29970022 |
| 64 | Ocular albinism (HP:0001107) | 2.26453257 |
| 65 | Eosinophilia (HP:0001880) | 2.26104706 |
| 66 | Drooling (HP:0002307) | 2.25912889 |
| 67 | Excessive salivation (HP:0003781) | 2.25912889 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.25578812 |
| 69 | Follicular hyperkeratosis (HP:0007502) | 2.25423784 |
| 70 | Abnormality of T cell number (HP:0011839) | 2.25213292 |
| 71 | Progressive hearing impairment (HP:0001730) | 2.24892251 |
| 72 | Increased mean platelet volume (HP:0011877) | 2.21861876 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.21760845 |
| 74 | Orchitis (HP:0100796) | 2.21015824 |
| 75 | Spinal rigidity (HP:0003306) | 2.19739000 |
| 76 | Dislocated radial head (HP:0003083) | 2.19131831 |
| 77 | Myocardial infarction (HP:0001658) | 2.18520699 |
| 78 | Urethral obstruction (HP:0000796) | 2.17230434 |
| 79 | Lower limb amyotrophy (HP:0007210) | 2.16313998 |
| 80 | Disinhibition (HP:0000734) | 2.14265122 |
| 81 | Widely spaced teeth (HP:0000687) | 2.13934809 |
| 82 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.13823767 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13187344 |
| 84 | Lip pit (HP:0100267) | 2.13123392 |
| 85 | Chromsome breakage (HP:0040012) | 2.10868024 |
| 86 | Joint laxity (HP:0001388) | 2.10654162 |
| 87 | Neurodegeneration (HP:0002180) | 2.10489104 |
| 88 | Progressive sensorineural hearing impairment (HP:0000408) | 2.10478629 |
| 89 | Thick nail (HP:0001805) | 2.10437400 |
| 90 | Hypoplasia of the thymus (HP:0000778) | 2.08917613 |
| 91 | Iris hypopigmentation (HP:0007730) | 2.08209558 |
| 92 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07299712 |
| 93 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.07154012 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 2.06957994 |
| 95 | Inappropriate behavior (HP:0000719) | 2.06641652 |
| 96 | Genetic anticipation (HP:0003743) | 2.06284789 |
| 97 | Broad face (HP:0000283) | 2.05872432 |
| 98 | Aortic regurgitation (HP:0001659) | 2.05293763 |
| 99 | Abnormal platelet volume (HP:0011876) | 2.04908889 |
| 100 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.04275682 |
| 101 | Osteomyelitis (HP:0002754) | 2.04111844 |
| 102 | Soft skin (HP:0000977) | 2.03888250 |
| 103 | Gingival bleeding (HP:0000225) | 2.01539325 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 2.01487348 |
| 105 | Inflammation of the large intestine (HP:0002037) | 2.01016756 |
| 106 | Abnormality of the columella (HP:0009929) | 1.98790696 |
| 107 | Viral hepatitis (HP:0006562) | 1.98737220 |
| 108 | Long toe (HP:0010511) | 1.98337779 |
| 109 | Broad ribs (HP:0000885) | 1.98101784 |
| 110 | Abnormal hair whorl (HP:0010721) | 1.97839913 |
| 111 | Pustule (HP:0200039) | 1.97782329 |
| 112 | Mitral stenosis (HP:0001718) | 1.97598610 |
| 113 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.97398676 |
| 114 | Aneurysm (HP:0002617) | 1.96666520 |
| 115 | Abnormality of the radial head (HP:0003995) | 1.96513175 |
| 116 | Mitral regurgitation (HP:0001653) | 1.95763799 |
| 117 | Agammaglobulinemia (HP:0004432) | 1.95109883 |
| 118 | Prominent nose (HP:0000448) | 1.94049567 |
| 119 | Increased connective tissue (HP:0009025) | 1.93436642 |
| 120 | Supranuclear gaze palsy (HP:0000605) | 1.93056542 |
| 121 | Abnormality of the prostate (HP:0008775) | 1.92950660 |
| 122 | Pelvic girdle muscle weakness (HP:0003749) | 1.92884254 |
| 123 | Orthostatic hypotension (HP:0001278) | 1.92433343 |
| 124 | IgA deficiency (HP:0002720) | 1.91426426 |
| 125 | Postural instability (HP:0002172) | 1.90214193 |
| 126 | Abnormal glucose tolerance (HP:0001952) | 1.88705472 |
| 127 | Short nail (HP:0001799) | 1.87543203 |
| 128 | Acute myeloid leukemia (HP:0004808) | 1.87488556 |
| 129 | Long eyelashes (HP:0000527) | 1.87128598 |
| 130 | Truncal obesity (HP:0001956) | 1.87088987 |
| 131 | Vertebral arch anomaly (HP:0008438) | 1.86547250 |
| 132 | Epistaxis (HP:0000421) | 1.86487326 |
| 133 | Abnormality of macrophages (HP:0004311) | 1.85331751 |
| 134 | Papillary thyroid carcinoma (HP:0002895) | 1.84195126 |
| 135 | Syringomyelia (HP:0003396) | 1.84155794 |
| 136 | Spinal cord lesions (HP:0100561) | 1.84155794 |
| 137 | Vertebral compression fractures (HP:0002953) | 1.84141506 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.84034962 |
| 139 | Protruding tongue (HP:0010808) | 1.83210395 |
| 140 | Abnormality of the peritoneum (HP:0002585) | 1.83107638 |
| 141 | Abnormality of eosinophils (HP:0001879) | 1.82823224 |
| 142 | Urinary urgency (HP:0000012) | 1.82630315 |
| 143 | Leukopenia (HP:0001882) | 1.81661832 |
| 144 | Cellulitis (HP:0100658) | 1.80583322 |
| 145 | Gastrointestinal inflammation (HP:0004386) | 1.80185241 |
| 146 | Pulmonary infiltrates (HP:0002113) | 1.79231655 |
| 147 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.77146919 |
| 148 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.77146919 |
| 149 | Meningitis (HP:0001287) | 1.76995686 |
| 150 | Abnormality of oral frenula (HP:0000190) | 1.76318465 |
| 151 | Blue sclerae (HP:0000592) | 1.75174461 |
| 152 | Bladder diverticulum (HP:0000015) | 1.74977607 |
| 153 | Type 1 muscle fiber predominance (HP:0003803) | 1.74795356 |
| 154 | Abnormality of B cell number (HP:0010975) | 1.73829930 |
| 155 | B lymphocytopenia (HP:0010976) | 1.73829930 |
| 156 | Gastrointestinal infarctions (HP:0005244) | 1.73768300 |
| 157 | Restrictive lung disease (HP:0002091) | 1.73589372 |
| 158 | Cerebral aneurysm (HP:0004944) | 1.73366963 |
| 159 | Shallow orbits (HP:0000586) | 1.72190767 |
| 160 | Fatigue (HP:0012378) | 1.72145501 |
| 161 | Impaired smooth pursuit (HP:0007772) | 1.72068880 |
| 162 | Gaze-evoked nystagmus (HP:0000640) | 1.71982668 |
| 163 | Aqueductal stenosis (HP:0002410) | 1.71740025 |
| 164 | Arterial thrombosis (HP:0004420) | 1.71495488 |
| 165 | Menorrhagia (HP:0000132) | 1.71279185 |
| 166 | Polycythemia (HP:0001901) | 1.69854680 |
| 167 | Decreased skull ossification (HP:0004331) | 1.69583513 |
| 168 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.69550858 |
| 169 | Papilledema (HP:0001085) | 1.69226317 |
| 170 | Mucosal telangiectasiae (HP:0100579) | 1.68963652 |
| 171 | Scanning speech (HP:0002168) | 1.68901021 |
| 172 | Resting tremor (HP:0002322) | 1.67753043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.57593700 |
| 2 | MAP3K13 | 3.27725724 |
| 3 | SIK2 | 3.20355462 |
| 4 | CDK12 | 2.79782531 |
| 5 | CAMK1G | 2.75772294 |
| 6 | MAP3K14 | 2.68223078 |
| 7 | PTK2B | 2.66354487 |
| 8 | MAP2K3 | 2.65154189 |
| 9 | BLK | 2.59470898 |
| 10 | TAOK3 | 2.42720845 |
| 11 | CAMK1D | 2.42404638 |
| 12 | MAP4K1 | 2.40272050 |
| 13 | TXK | 2.36598329 |
| 14 | PIK3CG | 2.36369812 |
| 15 | TYK2 | 2.13624992 |
| 16 | PDGFRA | 2.11800595 |
| 17 | KIT | 2.09255202 |
| 18 | BMPR2 | 1.92053863 |
| 19 | JAK1 | 1.87800480 |
| 20 | BRD4 | 1.79210771 |
| 21 | IKBKE | 1.74904711 |
| 22 | TIE1 | 1.71296193 |
| 23 | MOS | 1.66892784 |
| 24 | HCK | 1.59009543 |
| 25 | JAK3 | 1.56176474 |
| 26 | FES | 1.54633702 |
| 27 | GRK5 | 1.47074609 |
| 28 | YES1 | 1.45742302 |
| 29 | ITK | 1.44789497 |
| 30 | AKT3 | 1.43836510 |
| 31 | CDK6 | 1.43625573 |
| 32 | SYK | 1.36473419 |
| 33 | IKBKB | 1.32620578 |
| 34 | IRAK4 | 1.32138355 |
| 35 | DAPK2 | 1.31187066 |
| 36 | TTN | 1.27883745 |
| 37 | SGK2 | 1.26019739 |
| 38 | FGR | 1.25496915 |
| 39 | PTK2 | 1.25345190 |
| 40 | CSK | 1.18647345 |
| 41 | SGK3 | 1.18630286 |
| 42 | LCK | 1.15405605 |
| 43 | MAP3K9 | 1.14823575 |
| 44 | WNK1 | 1.13129446 |
| 45 | CSF1R | 1.12090593 |
| 46 | EPHB1 | 1.09880267 |
| 47 | KSR1 | 1.09716814 |
| 48 | ICK | 1.08730496 |
| 49 | TBK1 | 1.07823939 |
| 50 | ROCK2 | 1.05864614 |
| 51 | CHUK | 1.04308815 |
| 52 | SGK1 | 1.03475738 |
| 53 | MAP3K10 | 1.03394071 |
| 54 | HIPK2 | 1.02836645 |
| 55 | ZAP70 | 1.01803185 |
| 56 | FGFR3 | 1.00559240 |
| 57 | KSR2 | 0.99588795 |
| 58 | SCYL2 | 0.98296377 |
| 59 | MYLK | 0.95180475 |
| 60 | MELK | 0.94812078 |
| 61 | IRAK3 | 0.93894329 |
| 62 | RAF1 | 0.89469594 |
| 63 | MAP3K3 | 0.89067252 |
| 64 | LRRK2 | 0.88425071 |
| 65 | MAPK10 | 0.87463328 |
| 66 | TRPM7 | 0.86970490 |
| 67 | NTRK3 | 0.85797862 |
| 68 | PDGFRB | 0.85588101 |
| 69 | FLT3 | 0.85586124 |
| 70 | MAP3K5 | 0.84797657 |
| 71 | NTRK1 | 0.82723023 |
| 72 | TEC | 0.82025571 |
| 73 | DAPK1 | 0.81117350 |
| 74 | ADRBK1 | 0.81018545 |
| 75 | CAMKK2 | 0.79600108 |
| 76 | EGFR | 0.79482018 |
| 77 | PAK6 | 0.78493549 |
| 78 | MAP3K4 | 0.78278836 |
| 79 | PNCK | 0.78248476 |
| 80 | MAP3K6 | 0.75653052 |
| 81 | RIPK1 | 0.75650633 |
| 82 | IRAK2 | 0.75344290 |
| 83 | ATR | 0.75145109 |
| 84 | LATS1 | 0.74216034 |
| 85 | MAP3K1 | 0.72792551 |
| 86 | JAK2 | 0.72329933 |
| 87 | LYN | 0.71292292 |
| 88 | IRAK1 | 0.70225136 |
| 89 | PAK2 | 0.69815074 |
| 90 | TGFBR2 | 0.69341518 |
| 91 | CDK9 | 0.67233714 |
| 92 | RET | 0.66883696 |
| 93 | UHMK1 | 0.66736073 |
| 94 | MAPK7 | 0.66112606 |
| 95 | PRKD2 | 0.65996611 |
| 96 | SGK223 | 0.64140718 |
| 97 | SGK494 | 0.64140718 |
| 98 | CDK8 | 0.64023199 |
| 99 | PIM1 | 0.63440471 |
| 100 | TRIB3 | 0.63110409 |
| 101 | ERBB2 | 0.62543572 |
| 102 | FRK | 0.62499218 |
| 103 | CAMKK1 | 0.61587889 |
| 104 | NEK2 | 0.60476240 |
| 105 | CDC7 | 0.60368322 |
| 106 | PKN1 | 0.60011981 |
| 107 | MTOR | 0.59884829 |
| 108 | GRK7 | 0.59382847 |
| 109 | MAPK12 | 0.57863272 |
| 110 | CDC42BPA | 0.56906840 |
| 111 | PDK1 | 0.56640051 |
| 112 | DYRK1A | 0.56100663 |
| 113 | DDR2 | 0.56016331 |
| 114 | PRKCQ | 0.55352001 |
| 115 | STK10 | 0.54696373 |
| 116 | ATM | 0.52450752 |
| 117 | MATK | 0.51899741 |
| 118 | PAK3 | 0.51353682 |
| 119 | STK38 | 0.51231059 |
| 120 | STK4 | 0.50773856 |
| 121 | GRK6 | 0.50638640 |
| 122 | BTK | 0.50510341 |
| 123 | MARK3 | 0.50148055 |
| 124 | CAMK4 | 0.49640943 |
| 125 | MARK2 | 0.49621081 |
| 126 | MAP3K7 | 0.49187730 |
| 127 | FYN | 0.48533328 |
| 128 | MAP2K4 | 0.47325367 |
| 129 | CDK5 | 0.46557016 |
| 130 | NTRK2 | 0.45369642 |
| 131 | PLK2 | 0.45306555 |
| 132 | NEK9 | 0.44569666 |
| 133 | PRKAA2 | 0.44550569 |
| 134 | DMPK | 0.44079622 |
| 135 | MINK1 | 0.43589248 |
| 136 | ERBB3 | 0.43188555 |
| 137 | ERBB4 | 0.43043895 |
| 138 | MARK1 | 0.42810518 |
| 139 | MAPK8 | 0.42748658 |
| 140 | PKN2 | 0.42448415 |
| 141 | CLK1 | 0.41758221 |
| 142 | STK11 | 0.41742553 |
| 143 | MAP3K2 | 0.41133904 |
| 144 | PRKCH | 0.41085242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43628094 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.27800750 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08250617 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95850700 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.88193339 |
| 6 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.84824796 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83755341 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.82539193 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.80338450 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 1.71746923 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69926876 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69630278 |
| 13 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.62222612 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59511007 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.57928040 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49291204 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.49051269 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.48821786 |
| 19 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.45231980 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.43052699 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39979751 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.34276463 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32825311 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.31698175 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.31252232 |
| 26 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.28891942 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28880932 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27859424 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23416579 |
| 30 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.20860681 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.19780585 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.18581701 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17627449 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17439444 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.14480130 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.13129527 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12594035 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08789935 |
| 39 | Prostate cancer_Homo sapiens_hsa05215 | 1.07751685 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07111739 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06661484 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06222093 |
| 43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04507781 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.03427656 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03300486 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00778612 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96495012 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96241428 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95489006 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95367027 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 0.95345232 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94138702 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93599893 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92969307 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.92522072 |
| 56 | Glioma_Homo sapiens_hsa05214 | 0.92351995 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.91925953 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.91576452 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91302418 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90945177 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89712658 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89425537 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89074933 |
| 64 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88330185 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87738752 |
| 66 | Pathways in cancer_Homo sapiens_hsa05200 | 0.86682050 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86519032 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86252702 |
| 69 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.86065308 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.85602707 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85463169 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84300372 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.84106679 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83732774 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83180972 |
| 76 | Melanoma_Homo sapiens_hsa05218 | 0.81921055 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81460210 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.81375409 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80431861 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79583211 |
| 81 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79221111 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78989291 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78425541 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77983840 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77968979 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77757871 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77306007 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.76796686 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76305699 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75922226 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.73385624 |
| 92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73062937 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72559567 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72501306 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72471550 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72457667 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72400501 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.71545292 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70664999 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70407017 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.69582301 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.68118598 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67869920 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67761943 |
| 105 | Legionellosis_Homo sapiens_hsa05134 | 0.67564122 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67232803 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66142144 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65739264 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65572533 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64885092 |
| 111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64592111 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63573660 |
| 113 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63235340 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63048256 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.62369495 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.61757894 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.61541916 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58602195 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.58221829 |
| 120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57007591 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57004429 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56917436 |
| 123 | Axon guidance_Homo sapiens_hsa04360 | 0.56859528 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54879596 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.54775361 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52374591 |
| 127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52016025 |
| 128 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50494972 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49283424 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49236817 |

